Literature DB >> 8383010

Identification and characterization of a novel matrix-degrading protease from hormone-dependent human breast cancer cells.

Y E Shi1, J Torri, L Yieh, A Wellstein, M E Lippman, R B Dickson.   

Abstract

A novel matrix-degrading enzyme was identified from human breast cancer cells. This enzyme appears as major gelatinase in hormone-dependent breast cancer cell lines and has as an apparent molecular mass of 80 kDa on gelatin zymography. The 80-kDa enzyme has a unique metal ion specificity. In addition to calcium ions, the gelatinolytic activity can be supported by manganese and/or magnesium. Unlike 92- and 72-kDa gelatinases and other known members of the metalloproteinase family, the 80-kDa protease is not activated by p-aminophenylmercuric acetate and its gelatinolytic activity is not inhibited by tissue inhibitor of metalloproteinase 2. It is active over the pH range 7.5-9.5 with an optimum at pH 8.5. The enzyme degrades gelatin and type IV collagen. The proteolytic activity of the enzyme is inhibited by EDTA and leupeptin. These unique features clearly distinguish the 80-kDa protease from the known 92-and 72-kDa gelatinases. The expression of 80-kDa enzyme can be detected in hormone-dependent human breast cancer cell lines in vitro and in tumors grown from these cells in athymic nude mice.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8383010

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  34 in total

Review 1.  The cutting edge: membrane-anchored serine protease activities in the pericellular microenvironment.

Authors:  Toni M Antalis; Marguerite S Buzza; Kathryn M Hodge; John D Hooper; Sarah Netzel-Arnett
Journal:  Biochem J       Date:  2010-06-15       Impact factor: 3.857

2.  Serase-1B, a new splice variant of polyserase-1/TMPRSS9, activates urokinase-type plasminogen activator and the proteolytic activation is negatively regulated by glycosaminoglycans.

Authors:  Yuushi Okumura; Masaki Hayama; Etsuhisa Takahashi; Mieko Fujiuchi; Aki Shimabukuro; Mihiro Yano; Hiroshi Kido
Journal:  Biochem J       Date:  2006-12-15       Impact factor: 3.857

3.  HAI-2 suppresses the invasive growth and metastasis of prostate cancer through regulation of matriptase.

Authors:  C-H Tsai; C-H Teng; Y-T Tu; T-S Cheng; S-R Wu; C-J Ko; H-Y Shyu; S-W Lan; H-P Huang; S-F Tzeng; M D Johnson; C-Y Lin; P-W Hsiao; M-S Lee
Journal:  Oncogene       Date:  2013-10-14       Impact factor: 9.867

4.  Platelet-derived growth factor-C (PDGF-C) activation by serine proteases: implications for breast cancer progression.

Authors:  Newton J Hurst; Abdo J Najy; Carolyn V Ustach; Lisa Movilla; Hyeong-Reh Choi Kim
Journal:  Biochem J       Date:  2012-02-01       Impact factor: 3.857

Review 5.  Matriptase: potent proteolysis on the cell surface.

Authors:  Karin List; Thomas H Bugge; Roman Szabo
Journal:  Mol Med       Date:  2006 Jan-Mar       Impact factor: 6.354

6.  Alpha-1 Antitrypsin-Deficient Macrophages Have Increased Matriptase-Mediated Proteolytic Activity.

Authors:  Karina Krotova; George W Marek; Rejean L Wang; George Aslanidi; Brad E Hoffman; Nazli Khodayari; Farshid N Rouhani; Mark L Brantly
Journal:  Am J Respir Cell Mol Biol       Date:  2017-08       Impact factor: 6.914

7.  Inhibition of cyclooxygenase-2-mediated matriptase activation contributes to the suppression of prostate cancer cell motility and metastasis.

Authors:  C-J Ko; S-W Lan; Y-C Lu; T-S Cheng; P-F Lai; C-H Tsai; T-W Hsu; H-Y Lin; H-Y Shyu; S-R Wu; H-H Lin; P-W Hsiao; C-H Chen; H-P Huang; M-S Lee
Journal:  Oncogene       Date:  2017-04-03       Impact factor: 9.867

8.  Tumor detection by imaging proteolytic activity.

Authors:  Molly R Darragh; Eric L Schneider; Jianlong Lou; Paul J Phojanakong; Christopher J Farady; James D Marks; Byron C Hann; Charles S Craik
Journal:  Cancer Res       Date:  2010-02-09       Impact factor: 12.701

9.  Matriptase-2 inhibits HECV motility and tubule formation in vitro and tumour angiogenesis in vivo.

Authors:  Siobhan L Webb; Andrew J Sanders; Malcolm D Mason; Wen G Jiang
Journal:  Mol Cell Biochem       Date:  2012-12-13       Impact factor: 3.396

10.  Proteolysis of extracellular matrix by invadopodia facilitates human breast cancer cell invasion and is mediated by matrix metalloproteinases.

Authors:  T Kelly; Y Yan; R L Osborne; A B Athota; T L Rozypal; J C Colclasure; W S Chu
Journal:  Clin Exp Metastasis       Date:  1998-08       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.